Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Artesunate“
Suchtreffer
Begriffe & Kennungen
Artesunat
Eintrag öffnenArtesunate Amivas
Eintrag öffnenArtesunate Amivas · 4.1 Therapeutic indications · 1
Eintrag öffnenArtesunate Amivas · 4.3 Contraindications · 1
Eintrag öffnenArtesunate Amivas · 4.3 · Hypersensitivity to the active substance, to any other artemisinin antimalarial agent or to any of the excipie
Eintrag öffnenArtesunate Amivas · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenArtesunate Amivas · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenArtesunate Amivas · 4.5 · Co-administration of Artesunate Amivas with UGT inducers (e.g. nevirapine, ritonavir, rifampicin, carbamazepin
Eintrag öffnenArtesunate Amivas · 4.5 · Co-administration of intravenous artesunate with strong inhibitors of UGT enzymes (e.g. axitinib, vandetanib,
Eintrag öffnenArtesunate Amivas · 4.5 · Effect of artesunate and/or DHA on other medicinal products Limited data from in vitro studies and from clinic
Eintrag öffnenArtesunate Amivas · 4.5 · Effect of other medicinal products on artesunate and/or dihydroartemisinin (DHA) After intravenous administrat
Eintrag öffnenArtesunate Amivas · 4.5 · No clinical drug-drug interactions studies have been conducted with Artesunate Amivas.
Eintrag öffnenArtesunate Amivas · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenArtesunate Amivas · 4.8 Undesirable effects · 1
Eintrag öffnenArtesunate Amivas · 4.8 · 6 Organ Systems Very common Common Uncommon Not known Skin and Stevens- subcutaneous tissue Johnson disorders
Eintrag öffnenArtesunate Amivas · 4.8 · Adverse events considered at least possibly related to artesunate are listed below by body system, organ class
Eintrag öffnenArtesunate Amivas · 4.8 · Post-Artesunate Delayed Haemolysis (PADH) has been reported very commonly following effective treatment of sev
Eintrag öffnenArtesunate Amivas · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenArtesunate Amivas · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenArtesunate Amivas · 4.8 · Reticulocytopenia that resolves after completion of treatment with intravenous artesunate occurs commonly or v
Eintrag öffnen